Home » Article
We are excited to announce a special “Tailgate and Testing” event during the University of Florida’s upcoming football tailgate in partnership with Man Cave Health and the UF Health Cancer Center. As part of our mission to raise awareness about prostate cancer and promote early detection, we will be offering. Read More
In honor of veterans this month, we reflect on the remarkable advancements in prostate cancer care made possible by the tireless work of providers and researchers through the PCF-VA partnership across the U.S., and by the generous support of donors. Addressing an Unmet Need The Prostate Cancer Foundation’s partnership with. Read More
Dr. June M. Chan, Professor in the Departments of Urology and Epidemiology & Biostatistics at UCSF, was a guest on a recent PCF webinar on Heart Health and Prostate Cancer. She discussed current research on cardiovascular disease risk factors and prostate cancer, based on studies that have collected data on. Read More
Gainesville, FL – October 16, 2024 – Man Cave Health, in partnership with the UF Health Cancer Center and the Prostate Cancer Foundation, is excited to announce a special “Tailgate and Testing” event during the University of Florida’s upcoming football tailgate. As part of our mission to raise awareness about. Read More
Step into “soup season” with PCF’s October recipe, Baked and Blended Pumpkin Soup! Perfect for autumn, whip up (literally!) this recipe for an easy meal for the entire family. With a few simple steps, you’ll have a warm and hearty bowl of goodness…that also provides great health benefits. Pumpkin is. Read More
Apply for This Job About the Prostate Cancer Foundation The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has been responsible for raising close to $1 billion in support of cutting-edge research by more than 2,200 research projects at. Read More
Since 2016, PCF has partnered with the VA Health System, funding Centers of Excellence around the country to speed research, treatments, and cures to Veterans with prostate cancer. Outside of the formal partnership, Veterans themselves are some of the strongest voices and most dedicated advocates. Meet Chuck Byers, a Vietnam. Read More
Phil participated in PCF’s 108 Miles in September Challenge and is generously sharing more of his story. He notes that while he has been involved in similar exercise- and fitness-based fundraisers in the past, this time, “It hits you a lot harder….it was a lot more meaningful after I was. Read More
Decipher® Score: A Tool to Guide Treatment for Advanced Prostate Cancer Currently, the standard of care treatment for metastatic hormone-sensitive prostate cancer (mHSPC) includes: Hormone therapy (ADT) + an androgen receptor pathway inhibitor (ARPI) such as enzalutamide or abiraterone ADT + the chemotherapy drug docetaxel ADT + ARPI + docetaxel Which. Read More
Clinicians and researchers gathered earlier this month at the European Society of Medical Oncology Congress 2024 in Barcelona. Hundreds of presentations covered advances in cancer research, including groundbreaking new clinical trial data in prostate cancer. While survival for patients with metastatic hormone-sensitive prostate cancer (mHSPC) and with metastatic castration-resistant prostate cancer. Read More